News & Events

HaemaLogiX announces issuance of US patent for LMA

Image-empty-state.png

27 September 2022

Watch: Chief Manufacturing and Development Officer Tertia Dex explains the KappaMab manufacturing process

Image-empty-state.png

15 August 2022

HaemaLogiX strengthens Board with appointment of Dr. Geoff Nichol

Image-empty-state.png

7 July 2022

HaemaLogiX announces issuance of USA patent for KMA.CAR T

Image-empty-state.png

7 July 2022

HaemaLogiX and Lonza Collaborate to Manufacture KappaMab, a Multiple Myeloma Drug Candidate

Image-empty-state.png

27 January 2022

HaemaLogiX welcomes Tertia Dex to the team

Image-empty-state.png

17 January 2022

HaemaLogiX welcomes Professor Simon Harrison to the SAB

Image-empty-state.png

21 December 2021

Full presentation materials on the novel antigens LMA and KMA at the 63rd annual ASH meeting are now available

Image-empty-state.png

15 December 2021

Dr Mary Sartor to present research on LMA and the 10B3 monoclonal antibody developed by HaemaLogiX at ASH 2021

Image-empty-state.png

5 November 2021

Platinum leads immuno-oncology company HaemaLogiX’s $10m capital-raising round

Image-empty-state.png

12 September 2021

HaemaLogiX raises $10 million to advance multiple myeloma treatments

Image-empty-state.png

8 September 2021

HaemaLogiX announces collaboration with the Peter MacCallum Cancer Centre

Image-empty-state.png

5 February 2021

Orphan Drug Designation for KappaMab transferred to HaemaLogiX

Image-empty-state.png

29 January 2021

HaemaLogiX announces issuance of Australian patent for LMA

Image-empty-state.png

22 January 2021

HaemaLogiX Announces the Outcomes of Two Innovation Connections Grant Projects

Image-empty-state.png

16 October 2020

Bryce Carmine to present at AusBiotech & Invest 2020

Image-empty-state.png

9 October 2020

HaemaLogiX announces results of collaboration with CellVec

Image-empty-state.png

2 October 2020

HaemaLogiX announces issuance of Australian patent for KMA.CAR

Image-empty-state.png

25 September 2020

Prof Andrew Spencer presents KappaMab Phase 2b interim analysis results at ASH 2019

Image-empty-state.png

8 December 2019

HaemaLogiX initiates collaboration with Universidad de Navarra

Image-empty-state.png

5 November 2019

HaemaLogiX initiates collaboration with TPL Path Labs

Image-empty-state.png

7 May 2019

KMA.CAR-T cell preclinical data poster presentation at AACR 2018

Image-empty-state.png

16 April 2018